These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
280 related articles for article (PubMed ID: 20935219)
1. Deficiencies in the Fanconi anemia DNA damage response pathway increase sensitivity to HPV-associated head and neck cancer. Park JW; Pitot HC; Strati K; Spardy N; Duensing S; Grompe M; Lambert PF Cancer Res; 2010 Dec; 70(23):9959-68. PubMed ID: 20935219 [TBL] [Abstract][Full Text] [Related]
2. The fanconi anemia pathway limits human papillomavirus replication. Hoskins EE; Morreale RJ; Werner SP; Higginbotham JM; Laimins LA; Lambert PF; Brown DR; Gillison ML; Nuovo GJ; Witte DP; Kim MO; Davies SM; Mehta PA; Butsch Kovacic M; Wikenheiser-Brokamp KA; Wells SI J Virol; 2012 Aug; 86(15):8131-8. PubMed ID: 22623785 [TBL] [Abstract][Full Text] [Related]
3. High incidence of HPV-associated head and neck cancers in FA deficient mice is associated with E7's induction of DNA damage through its inactivation of pocket proteins. Park JW; Shin MK; Pitot HC; Lambert PF PLoS One; 2013; 8(9):e75056. PubMed ID: 24086435 [TBL] [Abstract][Full Text] [Related]
4. Loss of Dependence on Continued Expression of the Human Papillomavirus 16 E7 Oncogene in Cervical Cancers and Precancerous Lesions Arising in Fanconi Anemia Pathway-Deficient Mice. Park S; Park JW; Pitot HC; Lambert PF mBio; 2016 May; 7(3):. PubMed ID: 27190216 [TBL] [Abstract][Full Text] [Related]
6. High incidence of female reproductive tract cancers in FA-deficient HPV16-transgenic mice correlates with E7's induction of DNA damage response, an activity mediated by E7's inactivation of pocket proteins. Park JW; Shin MK; Lambert PF Oncogene; 2014 Jun; 33(26):3383-91. PubMed ID: 24013229 [TBL] [Abstract][Full Text] [Related]
7. Assessing the spectrum of germline variation in Fanconi anemia genes among patients with head and neck carcinoma before age 50. Chandrasekharappa SC; Chinn SB; Donovan FX; Chowdhury NI; Kamat A; Adeyemo AA; Thomas JW; Vemulapalli M; Hussey CS; Reid HH; Mullikin JC; Wei Q; Sturgis EM Cancer; 2017 Oct; 123(20):3943-3954. PubMed ID: 28678401 [TBL] [Abstract][Full Text] [Related]
8. FANCD2 Binds Human Papillomavirus Genomes and Associates with a Distinct Set of DNA Repair Proteins to Regulate Viral Replication. Spriggs CC; Laimins LA mBio; 2017 Feb; 8(1):. PubMed ID: 28196964 [TBL] [Abstract][Full Text] [Related]
9. Molecular profile of head and neck squamous cell carcinomas bearing p16 high phenotype. Rampias T; Pectasides E; Prasad M; Sasaki C; Gouveris P; Dimou A; Kountourakis P; Perisanidis C; Burtness B; Zaramboukas T; Rimm D; Fountzilas G; Psyrri A Ann Oncol; 2013 Aug; 24(8):2124-31. PubMed ID: 23406730 [TBL] [Abstract][Full Text] [Related]
10. The human papillomavirus type 16 E7 oncoprotein activates the Fanconi anemia (FA) pathway and causes accelerated chromosomal instability in FA cells. Spardy N; Duensing A; Charles D; Haines N; Nakahara T; Lambert PF; Duensing S J Virol; 2007 Dec; 81(23):13265-70. PubMed ID: 17898070 [TBL] [Abstract][Full Text] [Related]
11. Genomic instability in mice is greater in Fanconi anemia caused by deficiency of Fancd2 than Fancg. Reliene R; Yamamoto ML; Rao PN; Schiestl RH Cancer Res; 2010 Dec; 70(23):9703-10. PubMed ID: 21118969 [TBL] [Abstract][Full Text] [Related]
12. High-risk human papillomavirus oncogenes disrupt the Fanconi anemia DNA repair pathway by impairing localization and de-ubiquitination of FancD2. Khanal S; Galloway DA PLoS Pathog; 2019 Feb; 15(2):e1007442. PubMed ID: 30818369 [TBL] [Abstract][Full Text] [Related]
13. Identification of biomarkers that distinguish human papillomavirus (HPV)-positive versus HPV-negative head and neck cancers in a mouse model. Strati K; Pitot HC; Lambert PF Proc Natl Acad Sci U S A; 2006 Sep; 103(38):14152-7. PubMed ID: 16959885 [TBL] [Abstract][Full Text] [Related]
14. DEK promotes HPV-positive and -negative head and neck cancer cell proliferation. Adams AK; Hallenbeck GE; Casper KA; Patil YJ; Wilson KM; Kimple RJ; Lambert PF; Witte DP; Xiao W; Gillison ML; Wikenheiser-Brokamp KA; Wise-Draper TM; Wells SI Oncogene; 2015 Feb; 34(7):868-77. PubMed ID: 24608431 [TBL] [Abstract][Full Text] [Related]
15. A novel role for Fanconi anemia (FA) pathway effector protein FANCD2 in cell cycle progression of untransformed primary human cells. Song IY; Barkley LR; Day TA; Weiss RS; Vaziri C Cell Cycle; 2010 Jun; 9(12):2375-88. PubMed ID: 20519958 [TBL] [Abstract][Full Text] [Related]
16. Pocket proteins suppress head and neck cancer. Shin MK; Pitot HC; Lambert PF Cancer Res; 2012 Mar; 72(5):1280-9. PubMed ID: 22237625 [TBL] [Abstract][Full Text] [Related]
17. Coordination of the recruitment of the FANCD2 and PALB2 Fanconi anemia proteins by an ubiquitin signaling network. Bick G; Zhang F; Meetei AR; Andreassen PR Chromosoma; 2017 Jun; 126(3):417-430. PubMed ID: 27277787 [TBL] [Abstract][Full Text] [Related]
18. FANCD2 and DNA Damage. Nepal M; Che R; Ma C; Zhang J; Fei P Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28825622 [TBL] [Abstract][Full Text] [Related]
19. FANCD2 limits acetaldehyde-induced genomic instability during DNA replication in esophageal keratinocytes. Peake JD; Noguchi C; Lin B; Theriault A; O'Connor M; Sheth S; Tanaka K; Nakagawa H; Noguchi E Mol Oncol; 2021 Nov; 15(11):3109-3124. PubMed ID: 34328261 [TBL] [Abstract][Full Text] [Related]
20. Heterozygosity for p53 (Trp53+/-) accelerates epithelial tumor formation in fanconi anemia complementation group D2 (Fancd2) knockout mice. Houghtaling S; Granville L; Akkari Y; Torimaru Y; Olson S; Finegold M; Grompe M Cancer Res; 2005 Jan; 65(1):85-91. PubMed ID: 15665282 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]